A recent study published in the Journal of American Nutrition Association shows that bis hexanoyl (R)-1,3-butanediol (BH-BD), the active ingredient in Metabolic Switch™, induces...
Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced clinical development progress for LMN-201, an investigational orally delivered cocktail...
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic...
BeiGene, Ltd., a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, announced...
QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, announced it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID...
